These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33734616)

  • 21. N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
    Hu Z; Zhu L; Zhang Y; Chen B
    Bioengineered; 2022 Feb; 13(2):3093-3107. PubMed ID: 35068325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
    Gao Z; Shi R; Yuan K; Wang Y
    Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meiotic nuclear divisions 1 promotes proliferation and metastasis in hepatocellular carcinoma and is a potential diagnostic and therapeutic target gene.
    Tan K; Wang K; Zhao A; Liu Z; Song W; Cheng Q; Li X; Chen Z; Yuan Y; Yang Z
    Med Oncol; 2022 Nov; 40(1):14. PubMed ID: 36352167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation.
    Zhu HE; Li T; Shi S; Chen DX; Chen W; Chen H
    J Exp Clin Cancer Res; 2021 Feb; 40(1):64. PubMed ID: 33573689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma.
    Zhang X; Yu K; Ma L; Qian Z; Tian X; Miao Y; Niu Y; Xu X; Guo S; Yang Y; Wang Z; Xue X; Gu C; Fang W; Sun J; Yu Y; Wang J
    Theranostics; 2021; 11(12):5650-5674. PubMed ID: 33897873
    [No Abstract]   [Full Text] [Related]  

  • 27. G protein gamma 7 suppresses progression of lung adenocarcinoma by inhibiting E2F transcription factor 1.
    Zheng H; Tian H; Yu X; Ren P; Yang Q
    Int J Biol Macromol; 2021 Jul; 182():858-865. PubMed ID: 33864871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 29. FOXA1/MND1/TKT axis regulates gastric cancer progression and oxaliplatin sensitivity via PI3K/AKT signaling pathway.
    Hu X; Zhou S; Li H; Wu Z; Wang Y; Meng L; Chen Z; Wei Z; Pang Q; Xu A
    Cancer Cell Int; 2023 Oct; 23(1):234. PubMed ID: 37817120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function.
    Britschgi A; Trinh E; Rizzi M; Jenal M; Ress A; Tobler A; Fey MF; Helin K; Tschan MP
    Oncogene; 2008 Sep; 27(43):5706-16. PubMed ID: 18521079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
    Zhu HE; Yin JY; Chen DX; He S; Chen H
    Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
    Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
    Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
    [No Abstract]   [Full Text] [Related]  

  • 35. LncRNA CASC2 inhibits lung adenocarcinoma progression through forming feedback loop with miR-21/p53 axis.
    Wu ZH; Zhou J; Hu GH; Liu J; Li WC; Lai XH; Liu M
    Kaohsiung J Med Sci; 2021 Aug; 37(8):675-685. PubMed ID: 34337857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonnegative matrix factorization-based bioinformatics analysis reveals that TPX2 and SELENBP1 are two predictors of the inner sub-consensuses of lung adenocarcinoma.
    Wang H; Wang X; Xu L; Cao H; Zhang J
    Cancer Med; 2021 Dec; 10(24):9058-9077. PubMed ID: 34734491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
    Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
    Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
    Xu Y; Lin L; Lv D; Yan S; He S; Ge H
    Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma.
    Liang J; Bi G; Huang Y; Zhao G; Sui Q; Zhang H; Bian Y; Yin J; Wang Q; Chen Z; Zhan C
    Drug Resist Updat; 2024 Mar; 73():101057. PubMed ID: 38266355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.